The King Hussein Cancer Center, is a medical center in Amman, Jordan. It treats both adult and pediatric patients. KHCC treats over 3500 new cancer patients every year from Jordan and the region. The Center was initially named Al-Amal center founded in 1997 by the late King Hussein.

During the past decade, King Hussein Cancer Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Hussein Cancer Center" #1 sponsor was "King Hussein Cancer Center" with 13 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Hikma Pharmaceuticals LLC" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Ali Shamseddine" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Hussein Cancer Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Phoenix Clinical Research" with 2 trials as a collaborator, "ACDIMA Biocenter" with 1 trials as a collaborator, "Amman Pharmaceutical Industries (API)" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "King Hussein Cancer Center" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Radiation Toxicity" (2 trials), "2019 Novel Coronavirus" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "King Hussein Cancer Center" in a lesser frequency.

Most popular intervention types in "King Hussein Cancer Center" are "Drug" (17 trials), "Radiation" (3 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control" (2 trials), "Apalutamide" (1 trials), "COMPOUND 2055269" (1 trials), "Compound 121564" (1 trials) and "Crizotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Hussein Cancer Center" are 22 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "King Hussein Cancer Center". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in King Hussein Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in King Hussein Cancer Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".